Medical Equipment Market Share: 2026 Report

From January through May 2026, our research team analyzed regulatory filings, annual reports, and industry benchmarking data from more than 100 leading medical device manufacturers worldwide. The dataset covers revenue performance and product category distribution. It also tracks the regional market trends shaping procurement decisions in 2026.

The global medical equipment market reached $604.99 billion in 2026, up from $572.31 billion in 2025, a 5.7% year-over-year increase. North America holds its position as the dominant regional market, and in-vitro diagnostics leads all product categories by market share. The tables below compile the most current benchmarks available for hospital administrators and purchasing directors.

Global Medical Device Market Overview

The global market grew at a steady rate in 2025 and accelerated in 2026, supported by rising rates of chronic disease, expanded approvals for AI devices, and broader access to minimally invasive procedures across both hospitals and ambulatory surgery centers.

Market Metric	2025 Value	2026 Value	2034 Projection	CAGR (2026–2034)
Global Market Size	$572.31B	$604.99B	$1,032.66B	6.90%
North America Market	$218.26B	$230.62B	est. $350B+	~4.5%
Asia Pacific Market	~$142B	$153.58B	est. $250B+	7.56%
Europe Market	~$148B	$154.82B	est. $240B+	~4.2%
Latin America Market	~$37B	$39.87B	est. $65B+	~5.8%

Key Insights:

• The global medical device market will exceed $1 trillion by 2034, growing at a 6.90% CAGR from 2026.
• Asia Pacific leads in growth rate, advancing at 7.56% CAGR through 2031, the fastest of any region.
• North America's market reached $230.62 billion in 2026, driven by Medicare reimbursement expansion and record FDA approvals.

Top Medical Equipment Manufacturers by Revenue

The following rankings draw from the Medtech Big 100 report published by Medical Design & Outsourcing and MassDevice, which ranks companies by annual medical device revenue. Where companies operate across multiple sectors, only device-segment revenue is counted.

Rank	Company	FY2025 Revenue	HQ	Primary Segment
1	Medtronic	$33.5B	Ireland/US	Cardiovascular, neuroscience
2	Johnson & Johnson MedTech	$31.9B	US	Orthopedics, surgery
3	Medline Industries	$25.5B	US	Medical supplies, distribution
4	Siemens Healthineers	$24.2B	Germany	Diagnostic imaging
5	Stryker	$22.6B	US	Orthopedics, robotics
6	GE HealthCare	$19.7B	US	Imaging, monitoring
7	Royal Philips	$19.5B	Netherlands	Patient monitoring
8	Abbott Laboratories	$19.0B	US	Diagnostics, cardiovascular
9	Boston Scientific	$16.7B	US	Interventional devices
10	Becton Dickinson	$15.1B	US	Medical technology

Key Insights:

• The top three companies generated over $90 billion in combined annual revenue.
• Medtronic reported Q3 FY2026 worldwide revenue of $9.017 billion, its highest enterprise growth in 10 quarters at 8.7%, with cardiovascular leading at 13.1% segment growth.
• J&J MedTech is positioned to claim the top spot as Medtronic completes its MiniMed diabetes spinoff, removing approximately $2.8 billion in annual device revenue from Medtronic's total.

Market Share by Product Category

Product category performance in 2026 reflects the converging pressures of chronic disease prevalence, AI integration, and the expansion of minimally invasive surgical techniques. In vitro diagnostics claimed the top spot in product-type market share.

Product Category	2025 Market Share	2026 Revenue Est.	Growth Driver
Diagnostic Imaging	20.0%	~$121B	AI integration, photon-counting CT
In-Vitro Diagnostics (IVD)	13.53%	~$82B	Chronic disease testing volume
Cardiovascular Devices	16.7%	~$101B	Aging population, transcatheter valves
Surgical Equipment	18.0%	~$109B	Minimally invasive procedures, robotics
Orthopedic Devices	8.8%	~$53B	Joint replacement, ASC expansion
Ophthalmic Devices	6.9%	~$42B	Vision correction technology

*IVD holds the dominant product-type market share per Fortune Business Insights' 2026 dataset.

Key Insights:

• IVD ranks as the dominant product type segment in 2026, driven by the growing global volume of clinical diagnostic tests.
• Surgical equipment growth accelerates as robotic-assisted procedures expand from hospital ORs into ambulatory surgery centers.
• Cardiovascular devices benefited from transcatheter valve procedures, which grew 22% year-over-year in 2024 and carried upward momentum into 2026.

Regional Market Distribution

North America holds structural dominance, but Asia Pacific's growth trajectory continues to narrow the gap. The U.S. alone reached $210.45 billion in 2026, bolstered by strong Medicare reimbursement frameworks and an FDA pipeline clearing AI-enabled devices at a record pace.

Region	2026 Market Size	% of Global Market	2026–2031 CAGR	Key Characteristic
North America	$230.62B	~38.1%	~4.5%	Dominant market; AI reimbursement leader
Europe	$154.82B	~25.6%	~4.2%	EU MDR compliance investment
Asia Pacific	$153.58B	~25.4%	7.56%	Fastest-growing; manufacturing expansion
Latin America	$39.87B	~6.6%	~5.8%	Emerging healthcare infrastructure
Middle East & Africa	~$20B	~3.3%	~4.0%	Government-funded hospital expansion

Key Insights:

• North America and Europe together account for nearly two-thirds of global medical device spending.
• China ($47.42B) and Japan ($43.86B) lead Asia Pacific's expansion, with India ($17.86B) rounding out the top three country markets in the region.
• The Middle East is seeing sustained growth in large-scale hospital investment, with Saudi Arabia alone allocating SAR 100 billion to build 20 new hospitals.

2026 Trend Spotlight: Surgical Robotics, AI, and the ASC Shift

Three forces reshape medical equipment procurement decisions in 2026. Each carries direct implications for what facilities buy and what they pay.

Segment	2026 Market Value	CAGR (2026–2034)	Key Development
Surgical Robotics	$15.98B	16.9%	da Vinci 5, Hugo, MAKO RPS, Ottava
AI/ML-Enabled Devices	1,300+ FDA authorizations	Expanding	Radiology, surgical guidance, monitoring
Wearable & Remote Monitoring	Significant share	7.23% (to 2031)	Hospital-at-home, CGM expansion
Ambulatory Surgery Centers	Growing segment	7.99% (to 2031)	CMS outpatient code expansion

Key Insights:

• Surgical robotics has the highest growth rate of any tracked segment, at a 16.9% CAGR, with the market reaching $15.98 billion in 2026 and projected to reach $55.74 billion by 2034.
• AI/ML-enabled devices surpassed 1,300 cumulative FDA authorizations by the end of 2025, with 74% concentrated in radiology, and each clearance generating its own CPT code and recurring revenue stream.
• Ambulatory surgery centers represent the fastest-growing end-user segment at 7.99% CAGR, as CMS expands outpatient reimbursement codes for high-acuity procedures.

Request a PDF Copy of This Report

Contact XS Supply today to receive your comprehensive "Medical Equipment Market Share: 2026 Report" report in PDF format.

XS Supply only purchases from hospitals, surgical centers, and other vetted industry vendors. XS Supply does not purchase personal medical supplies from individuals.